The potential role of BAX and BCL-2 expression in diffuse alveolar damage

American Journal of Pathology

Volumn 151, Issue 4, 1997, Pages 999-1007

  Guinee Jr , Donald ^a,e   Brambilla, Elisabeth ^b   Fleming, Marian ^c   Hayashi, Tomayoshi ^c   Rahn, Mark ^a   Koss, Michael ^c   Ferrans, Victor ^d   Travis, William ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLITIS; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG INJURY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ADULT; AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHILD; CHILD, PRESCHOOL; EPITHELIUM; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PULMONARY ALVEOLI;

EID: 1842373294     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Katzenstein AL, Bloor CM, Liebow AA: Diffuse alveolar damage-the role of oxygen, shock, and related factors. Am J Pathol 1976, 85:210-228
2. Nash G, Blennerhassett JB, Pontoppidan H: Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Engl J Med 1967, 276:368-374
3. Collins JF, Smith JD, Coalson JJ, Johanson WGJ: Variability in lung collagen amounts after prolonged support of acute respiratory failure. Chest 1984, 85:641-646
4. Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, Masugi Y: The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol 1987, 126:171-182
5. Gould VE, Tosco R, Wheelis RF, Gould NS, Kapanci Y: Oxygen pneumonitis in man: ultrastructural observations on the development of alveolar lesions. Lab Invest 1972, 26:499-508
6. Katzenstein AL, Myers JL, Mazur MT: Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986, 10:256-267
7. Kapanci Y, Tosco R, Eggermann J, Gould VE: Oxygen pneumonitis in man: light and electron microscopic morphometric studies. Chest 1972, 62:162-169
8. Nash G, Foley FD, Langlinais PC: Pulmonary interstitial edema and hyaline membranes in adult burn patients: electron microscopic observations. Hum Pathol 1974, 5:149-160
9. Bachofen M, Weibel ER: Basic pattern of tissue repair in human lungs following unspecific injury. Chest 1974, 65(suppl):14S-19S
10. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1967, 2:319-323
11. Blaisdell FW, Schlobohm RM: The respiratory distress syndrome: a review. Surgery 1973, 74:251-262
12. Greene R: Adult respiratory distress syndrome: acute alveolar damage. Radiology 1987, 163:57-66
13. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress. Am Rev Respir Dis 1988, 138:720-723
14. Martin AM, Soloway HB, Simmons RL: Pathologic anatomy of the lungs following shock and trauma. J Trauma 1968, 8:687-699
15. Katzenstein AL: Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study. Hum Pathol 1985, 16:1015-1024
16. Bardales RH, Xie S, Schaefer RF, Hsu S: Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996, 149:845-852
17. Guinee DG, Jr., Fleming M, Hayashi T, Woodward M, Zhang J, Walls J, Koss M, Ferrans V, Travis W: Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. Am J Pathol 1996, 149:531-538
18. Oltvai Z, Milliman C, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619
19. Yang E, Korsmeyer S: Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996, 88:386-401
20. Norton AJ, Jordan S, Yeomans P: Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994, 173:371-379
21. Taylor CR, Shi S, Cote RJ: Antigen retrieval for immunohistochemistry: status and need for greater standardization. Appl Immunohistochem 1996, 4:144-166
22. Giorno R: A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 1984, 2:161-166
23. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994, 145:1323-1336
24. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311
25. Braun SR, DoPico GA, Olson CE, Caldwell W: Low-dose radiation pneumonitis. Cancer 1975, 35:1322-1324
26. Gross NJ: The pathogenesis of radiation-induced lung damage. Lung 1981, 159:115-125
27. Trask CW, Joannides T, Harper PG, Tobias JS, Spiro SG, Geddes DM, Souhami RL, Beverly PC: Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high-dose cyclophosphamide. Cancer 1985, 55:57-60
28. Cooper JA, Jr., White DA, Matthay RA: Drug-induced pulmonary disease: 1. cytotoxic drugs. Am Rev Respir Dis 1986, 133:321-340
29. Mustafa MG, Tierney DF: Biochemical and metabolic changes in the lung with oxygen, ozone, and nitrogen dioxide toxicity. Am Rev Respir Dis 1978, 118:1061-1090
30. Maity A, McKenna WG, Muschel RJ: The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 1994, 31:1-13
31. Deneke SM, Fanburg BL: Normobaric oxygen toxicity of the lung. N Engl J Med 1980, 303:76-86
32. Frank L, Massaro D: Oxygen toxicity. Am J Med 1980, 69:117-126
33. Fridovich I: Superoxide dismutase in biology and medicine. Pathology of Oxygen. Edited by Autor AP. New York, Academic Press, 1982, pp 1-19
34. Bertrand Y: Oxygen-free radicals and lipid peroxidation in adult respiratory distress syndrome. Intensive Care Med 1985, 11:56-60
35. Murphy PG, Myers DS, Webster NR, Jones JG, Davies MJ: Direct detection of free radical generation in an in vivo model of acute lung injury. Free Radic Res Commun 1991, 15:167-176
36. Wood KA, Youle RJ: Apoptosis and free radicals. Ann NY Acad Sci 1994, 738:400-407
37. Till GO, Friedl HP, Ward PA: Lung injury and complement activation: role of neutrophils and xanthine oxidase. Free Radic Biol Med 1991, 10:379-386
38. Korsmeyer SJ, Yin XM, Oltvai ZN, Veis Novack DJ, Linette GP: Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta 1995, 1271:63-66
39. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN: Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993, 4:327-332
40. Krajewski S, Mai JK, Krajewska M, Sikorska M, Mossakowski MJ, Reed JC: Upregulation of bax protein levels in neurons following cerebral ischemia. J Neurosci 1995, 15:6364-6376
41. Borovitskaya AE, Evtushenko VI, Sabol SL: Gamma-radiation-induced cell death in the fetal rat brain possesses molecular characteristics of apoptosis and is associated with specific messenger RNA elevations. Brain Res Mol Brain Res 1996, 35:19-30
42. Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O'Connor PM, Fornace AJJ: Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 1994 9:3743-3751
43. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D: Immediate early up-regulation of bax expression by p53 but not TGF β 1 : a paradigm for distinct apoptotic pathways. Oncogene 1994, 9:1791-1798
44. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9:1799-1805
45. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299
46. Wagener C, Bargou RC, Daniel PT, Bommert K, Mapara MY, Royer HD, Dorken B: Induction of the death-promoting gene bax-α sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int J Cancer 1996, 67:138-141
47. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, Tsujimoto H, Imanishi T, Ohgaki M, Ohyama T, Yamazaki J, Hagiwara A, Yamaguchi T, Sawai K, Takahashi T: Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 1996, 67:101-105
48. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N: P21Waf1/Cip1/Sdi1, and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996, 154:477-483
49. Walker C, Robertson L, Myskow M, Dixon G: Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 1995, 72:164-169
50. Pezella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY: bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 1993, 329:690-694
51. Rao SK, Krishna M, Woda BA, Savas L, Fraire AE: Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular components. Mod Pathol 1996, 9:555-559
52. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80:879-886
53. Chen B, Polunovsky V, White J, Blazar B, Nakhleh R, Jessurun J, Peterson M, Bitterman P: Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype. J Clin Invest 1992, 90:1778-1785
54. Hooper RG, Kearl RA: Established adult respiratory distress syndrome successfully treated with corticosteroids. South Med J 1996, 89:359-364
55. Biffl WL, Moore FA, Moore EE, Haenel JB, McIntyre RC Jr, Burch JM: Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome? Am J Surg 1995, 170:591-595
56. Hooper RG, Kearl RA: Established ARDS treated with a sustained course of adrenocortical steroids. Chest 1990, 97:138-143
57. Meduri GU, Chinn AJ, Leeper KV, Wunderink RG, Tolley E, Winer Muram HT, Khare V, Eltorky M: Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest 1994, 105:1516-1527
58. Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, el Torky M, Leeper KVJ: Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids. Chest 1991, 100:943-952
59. Evans Storms RB, Cidlowski JA: Regulation of apoptosis by steroid hormones. J Steroid Biochem Mol Biol 1995, 53:1-8
60. Thompson EB: Apoptosis and steroid hormones. Mol Endocrinol 1994, 8:665-673
61. Lotem J, Sachs L: Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 1995, 6:647-653
62. O'Reilly LA, Huang DC, Strasser A: The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 1996, 15:6979-6990
63. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, Chinnadurai G: Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 1995, 11:1921-1928
64. Farrow SN, White JH, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC, Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995, 374:731-733
65. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995, 374:733-736
66. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995, 374:736-739
67. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-XL, and Bcl-2, displaces Bax, and promotes cell death. Cell 1995, 80:285-291
68. Boise LH, Gonzalez Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993 74:597-608
69. Fang W, Rivard JJ, Mueller DL, Behrens TW: Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J Immunol 1994, 153:4388-4398
70. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993, 90:3516-3520
71. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462
72. Henke C, Bitterman P, Roongta U, lngbar D, Polunovsky V: Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease. Am J Pathol 1996, 149: 1639-1650